Objectives: To describe prevalence and estimated attribution of human papillomavirus
(HPV) types in US cervical, vaginal, and vulvar precancers and cancers. Methods: US …

Background Natural history models of human papillomavirus (HPV) infection and disease
have been used in a number of policy evaluations of technologies to prevent and screen for …

This paper is concerned with the optimal influenza vaccine distribution in a heterogeneous
population consisting of multiple subgroups. We employ a compartmental model for …

We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent …

Background The cost-effectiveness of prophylactic vaccination against human
papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for …

We assessed the public health impact and value of vaccinating boys and men with the
quadrivalent HPV vaccine in the United States. We used mathematical population models …

Objective To assess the cost effectiveness of including preadolescent boys in a routine
human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost …

Vaccination ideally protects susceptible populations at high risk for complications of the
infection. However, vaccines for these subgroups do not always provide sufficient …

Cost effectiveness is becoming an increasingly important factor for stakeholders faced with
decisions about adding a new vaccine into national immunization programmes versus …

Abstract The World Health Organization recommends establishing that human
papillomavirus vaccination is cost-effective before vaccine introduction. We searched …